跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VANFLYTA 26,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VANFLYTA 26,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
VANFLYTA 26,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Daiichi Sankyo Europe Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 19, 2024
Approval ID
ef2f6c9fba643f7b
Company
Daiichi Sankyo Europe Gmbh
Type
Standard
Approval Details
Approval Id
ef2f6c9fba643f7b
Drug Cima Aemps Name
VANFLYTA 26,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1231768005
Holder Company Name
Daiichi Sankyo Europe Gmbh
Marketing Company Name
Daiichi Sankyo Espana S.A.
Holder Company Detail Path
/organization/daiichi-sankyo-europe-gmbh
Authorization Date
2024-03-19
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
26,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Daiichi Sankyo Europe Gmbh
Company Detail Path
/organization/daiichi-sankyo-europe-gmbh
Company Information
Pharmaceutical Company Name
Daiichi Sankyo Europe GmbH
Country Name
Germany
City Name
münchen,bayern,country_de
Address
Zielstattstr. 48
Website
http://www.daiichi-sankyo.eu
Active Ingredients
QUIZARTINIB DIHIDROCLORURO
26,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 19, 2024
Approval ID
ef2f6c9fba643f7b
Type
Standard
Back to CIMA-AEMPS Approvals
